US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
14.21
-0.02 (-0.11%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman
June 20, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
June 20, 2025
Via
ACCESS Newswire
IOVA COURT NOTICE: Lose Money on Iovance Biotherapeutics, Inc.? Contact BFA Law before Upcoming Class Action Deadline
June 19, 2025
Via
ACCESS Newswire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox Before July 14, 2025
June 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox Before July 14, 2025
June 18, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
June 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
June 18, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
June 17, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks And Legal Pressure - Hagens Berman
June 17, 2025
Via
ACCESS Newswire
IOVA NOTIFICATION: Iovance Biotherapeutics, Inc. Shareholders are Notified of The Ongoing Securities Fraud Class Action Lawsuit - Contact BFA Law by July 14
June 17, 2025
Via
ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm
June 16, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
IOVA SHAREHOLDER ALERT: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors of Upcoming July 14 Class Action Deadline - Contact the Firm if You Suffered Losses
June 16, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
June 15, 2025
From
Pomerantz LLP
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA
June 14, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
June 12, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
June 11, 2025
From
SkyMedia, LLC
Via
GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
June 10, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action Lawsuit - Contact Kaplan Fox
June 10, 2025
Via
TheNewswire.com
Topics
Lawsuit
Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action Lawsuit - Contact Kaplan Fox
June 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
June 10, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Iovance Biotherapeutics to Present at Upcoming Conference
June 10, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm
June 09, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
June 06, 2025
From
Pomerantz LLP
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
June 06, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA
June 05, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
June 04, 2025
From
SkyMedia, LLC
Via
GlobeNewswire
IOVANCE BIOTHERAPEUTICS DEADLINE IS JULY 14, 2025 - Investors are Encouraged to Contact Kaplan Fox
June 04, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
IOVANCE BIOTHERAPEUTICS DEADLINE IS JULY 14, 2025 - Investors are Encouraged to Contact Kaplan Fox
June 04, 2025
Via
TheNewswire.com
Topics
Lawsuit
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
June 03, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm
June 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
